New
In Stock
KEYTRUDA® (pembrolizumab)
- Stock: In Stock
$998.00
Available Options
Description
Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer.